帕金森病和光生物调节:治疗的潜力
Brian Bicknell1, Ann Liebert1,2,3, Geoffrey Herkes4,5
1NICM Health Research Institute, University of Western Sydney, Westmead 2145, Australia.
Journal of personalized medicine
|January 26, 2024
概括
光生物调制 (PBM) 疗法通过改善线粒体功能和减少炎症,对帕金森病有很大的希望. 早期的临床试验表明PBM可以缓解运动和非运动症状,可能减缓疾病的进展.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 光疗法是一种照明疗法.
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,其特点是运动和非运动症状,线粒体功能障碍和神经炎症.
- 肠-大脑轴在PD病变发生过程中发挥作用,影响炎症和α-synuclein聚合.
- 目前的治疗方法,如多巴胺替代疗法,可以缓解症状,但不能阻止疾病的进展,这凸显了新的治疗策略的必要性.
研究的目的:
- 探索光生物调制 (PBM) 作为帕金森病的辅助疗法的潜力.
- 在PD的背景下,研究PBM对线粒体功能,炎症和神经保护的影响.
- 评估PBM在改善帕金森病的运动和非运动症状方面的临床疗效.
主要方法:
- 对帕金森病的PBM进行临床前研究和现有临床试验的审查.
- 分析PBM提出的作用机制,包括增强线粒体电子运输链,ATP生产和调节细胞信号.
- 检查PBM应用方法,包括直接和远程 (全身) 治疗.
主要成果:
- 临床前研究表明,PBM可以改善临床症状,并在帕金森病的动物模型中提供神经保护.
- PBM显示出增强线粒体功能,增加ATP生产和减少炎症的潜力.
- 新兴的临床试验数据表明,PBM可以改善帕金森病患者的运动和非运动症状.
结论:
- 光生物调制 (PBM) 疗法为治疗帕金森病提供了一种有希望的非侵入性治疗方法.
- PBM针对线粒体功能障碍和神经炎症的能力提供了一个新的治疗途径.
- 需要进一步的临床研究来确定PBM的疗效和帕金森病治疗的最佳方案.
更多相关视频
06:56Near Infrared NIr Light Increases Expression of a Marker of Mitochondrial Function in the Mouse Vestibular Sensory Epithelium
Published on: March 14, 2015
9.9K
07:56Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases
Published on: June 28, 2024
730
相关概念视频
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:15Parkinson's Disease: Overview
547
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K